These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23703665)

  • 1. Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice.
    Jiang JX; Chen X; Fukada H; Serizawa N; Devaraj S; Török NJ
    Hepatology; 2013 Oct; 58(4):1339-48. PubMed ID: 23703665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice.
    Menghini R; Menini S; Amoruso R; Fiorentino L; Casagrande V; Marzano V; Tornei F; Bertucci P; Iacobini C; Serino M; Porzio O; Hribal ML; Folli F; Khokha R; Urbani A; Lauro R; Pugliese G; Federici M
    Gastroenterology; 2009 Feb; 136(2):663-72.e4. PubMed ID: 19027012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TACE inhibition: a promising therapeutic intervention against AATF-mediated steatohepatitis to hepatocarcinogenesis.
    Srinivas AN; Suresh D; Vishwanath PM; Satish S; Santhekadur PK; Koka S; Kumar DP
    Mol Oncol; 2024 Aug; 18(8):1940-1957. PubMed ID: 38558505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.
    Csak T; Velayudham A; Hritz I; Petrasek J; Levin I; Lippai D; Catalano D; Mandrekar P; Dolganiuc A; Kurt-Jones E; Szabo G
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G433-41. PubMed ID: 21233280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice.
    Fiorentino L; Vivanti A; Cavalera M; Marzano V; Ronci M; Fabrizi M; Menini S; Pugliese G; Menghini R; Khokha R; Lauro R; Urbani A; Federici M
    Hepatology; 2010 Jan; 51(1):103-10. PubMed ID: 19877183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo.
    Jiang JX; Venugopal S; Serizawa N; Chen X; Scott F; Li Y; Adamson R; Devaraj S; Shah V; Gershwin ME; Friedman SL; Török NJ
    Gastroenterology; 2010 Oct; 139(4):1375-84. PubMed ID: 20685364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans.
    Monroy A; Kamath S; Chavez AO; Centonze VE; Veerasamy M; Barrentine A; Wewer JJ; Coletta DK; Jenkinson C; Jhingan RM; Smokler D; Reyna S; Musi N; Khokka R; Federici M; Tripathy D; DeFronzo RA; Folli F
    Diabetologia; 2009 Oct; 52(10):2169-81. PubMed ID: 19633828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.
    Paik YH; Iwaisako K; Seki E; Inokuchi S; Schnabl B; Osterreicher CH; Kisseleva T; Brenner DA
    Hepatology; 2011 May; 53(5):1730-41. PubMed ID: 21384410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.
    Bettaieb A; Jiang JX; Sasaki Y; Chao TI; Kiss Z; Chen X; Tian J; Katsuyama M; Yabe-Nishimura C; Xi Y; Szyndralewiez C; Schröder K; Shah A; Brandes RP; Haj FG; Török NJ
    Gastroenterology; 2015 Aug; 149(2):468-80.e10. PubMed ID: 25888330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression.
    Ryu J; Kim E; Kang MK; Song DG; Shin EA; Lee H; Jung JW; Nam SH; Kim JE; Kim HJ; Son T; Kim S; Kim HY; Lee JW
    J Pathol; 2021 Jan; 253(1):55-67. PubMed ID: 32918742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TACE inhibition amplifies TNF-alpha-mediated colonic epithelial barrier disruption.
    Fréour T; Jarry A; Bach-Ngohou K; Dejoie T; Bou-Hanna C; Denis MG; Mosnier JF; Laboisse CL; Masson D
    Int J Mol Med; 2009 Jan; 23(1):41-8. PubMed ID: 19082505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
    Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
    Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.
    Dixon LJ; Berk M; Thapaliya S; Papouchado BG; Feldstein AE
    Lab Invest; 2012 May; 92(5):713-23. PubMed ID: 22411067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of TIMP3 leads to increase in TACE expression and TNFα production by placental trophoblast cells.
    Ma R; Gu B; Gu Y; Groome LJ; Wang Y
    Am J Reprod Immunol; 2014 May; 71(5):427-33. PubMed ID: 24495020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration.
    Aram G; Potter JJ; Liu X; Wang L; Torbenson MS; Mezey E
    Hepatology; 2009 Mar; 49(3):911-9. PubMed ID: 19072832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous 8-hydroxydeoxyguanosine ameliorates liver fibrosis through the inhibition of Rac1-NADPH oxidase signaling.
    Shin SK; Kim KO; Kim SH; Kwon OS; Choi CS; Jeong SH; Kim YS; Kim JH; Chung MH
    J Gastroenterol Hepatol; 2020 Jun; 35(6):1078-1087. PubMed ID: 31907970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet.
    Ibusuki R; Uto H; Arima S; Mawatari S; Setoguchi Y; Iwashita Y; Hashimoto S; Maeda T; Tanoue S; Kanmura S; Oketani M; Ido A; Tsubouchi H
    Liver Int; 2013 Nov; 33(10):1549-56. PubMed ID: 23682724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
    Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK
    Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonphagocytic Activation of NOX2 Is Implicated in Progressive Nonalcoholic Steatohepatitis During Aging.
    Jiang JX; Fish SR; Tomilov A; Li Y; Fan W; Dehnad A; Gae D; Das S; Mozes G; Charville GW; Ramsey J; Cortopassi G; Török NJ
    Hepatology; 2020 Oct; 72(4):1204-1218. PubMed ID: 31950520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.